LIN · NASDAQ-GS
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $33.99B | $33.01B | $32.85B | $33.36B | $30.79B | $27.24B | $28.23B | $14.84B |
| Research & Development | $147.00M | $150.00M | $146.00M | $143.00M | $143.00M | $152.00M | $184.00M | $113.00M |
| Selling, General & Administrative | $3.43B | $3.34B | $3.29B | $3.11B | $3.19B | $3.19B | $3.46B | $1.63B |
| Operating Income | $8.92B | $8.63B | $8.02B | $5.37B | $4.98B | $3.32B | $2.93B | $5.25B |
| Interest Expense | $575.00M | $555.00M | $480.00M | $277.00M | $227.00M | $277.00M | $284.00M | $297.00M |
| Income Before Taxes | $8.90B | $8.57B | $7.99B | $5.54B | $5.10B | $3.38B | $2.93B | $5.05B |
| Provision for Income Taxes | $1.99B | $2.00B | $1.81B | $1.43B | $1.26B | $847.00M | $769.00M | $817.00M |
| Net Income | $6.90B | $6.57B | $6.20B | $4.15B | $3.83B | $2.50B | $2.29B | $4.38B |
| Basic EPS | $14.69 | $13.71 | $12.70 | $8.30 | $7.40 | $4.75 | $4.22 | $13.26 |
| Diluted EPS | $14.61 | $13.62 | $12.59 | $8.23 | $7.33 | $4.71 | $4.19 | $13.11 |
| Basic Shares Outstanding | 469.49M | 478.77M | 488.19M | 499.74M | 516.90M | 526.74M | 541.09M | 330.40M |
| Diluted Shares Outstanding | 472.19M | 482.09M | 492.29M | 504.04M | 521.88M | 531.16M | 545.17M | 334.13M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $17.84 | $17.80 | $17.90 | 7 | ↑3 ↓2 |
| Dec 2027 | $19.61 | $19.45 | $19.75 | 10 | ↑7 ↓2 |
| Dec 2028 | $21.45 | $20.80 | $21.98 | 5 | ↑2 ↓1 |
| Dec 2029 | $24.68 | $24.68 | $24.68 | 1 | ↑0 ↓1 |